RESULTS OF ACUTE LYMPHOBLASTIC LEUKEMIA TREATMENT WITH INTENSIVE CHEMOTHERAPY IN CHILDREN IN ST.-PETERSBURG: RETROSPECTIVE EVALUATION OF TWO VERSIONS OF COALL-92 PROTOCOL
Abstract
Key words: children, acute lymphoblastic leukemia, intensive chemotherapy.
(Voprosy sovremennoi pediatrii — Current Pediatrics. 2011; 10 (3): 33–42)
About the Authors
E.G. BoichenkoE.M. Petrova
I.A. Garbusova
Yu.A. Nikitina
T.N. Kulakova
T.A. Makarova
M.B. Belogurova
G.G. Radulesku
T.D. Viktorovich
E.D. Chavpetsova
L.I. Shats
G.I. Uleiskaya
I.S. Martynkevich
Y.S. Ogorodnikova
E.E. Zueva
References
1. Алексеев Н.А., Воронцов И.М. Лейкозы у детей. Л.: Медицина. 1988. 248 с.
2. Bennett J., Catovsky D., Daniel M. et al. Proposals for the classification of the acute leukaemias. French–American–British (FAB) co–operative group. Br. J. Haematol. 1976; 33: 451–458.
3. Bene M., Castoldi G., Knapp W. et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia. 1995; 9(10): 1783–1786.
4. ISCN: An International System Human Cytogenetic Nomenclature (2005). Ed. Shaffer L.G., Tommerup N. Basel, Switzerland: Karger. 2005.
5. Harms D.O., Janka–Schaub G.E. Co-operative study group for childhood acute lymphoblastic leukemia (COALL): long-term follow-up of trials 82, 85, 89 and 92. Leukemia. 2000; 14 (12): 2234–2239.
6. Jurgens H., Janka G., Ibrahim M. et al. Prognostic significance of exposure to intermediate dose methotrexate in children with standard risk ALL: the COALL 82/85 experience. Hamatol. Bluttransfus. 1992; 34: 338–342.
7. Janka–Schaub G.E., Harms D., Goebel U. et al. Randomized comparison of rational chemotherapy in high-risk acute lymphoblastic leukaemia of childhood follow up after 9 years. Eur. J. Pediatr. 1996; 155: 640–648.
8. Бойченко Э.Г. Программная полихимиотерапия острого лимфобластного лейкоза у детей (протокол РЕСО-92). Автореф. дис. …канд. мед. наук. СПб. 2003. 23 с.
9. Лившиц М.С. Влияние постцитостатических лейко–нейтропений и обусловленных ими инфекционных осложнений на результаты лечения детского острого лимфобластного лейкоза (протокол PECO 92). Автореф. дис. …канд. мед. наук. СПб. 2005. 24 с.
10. Schrappe M., Reiter A., Zimmermann M. et al. Long term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Leukemia. 2000; 14: 2205–2222.
Review
For citations:
Boichenko E., Petrova E., Garbusova I., Nikitina Yu., Kulakova T., Makarova T., Belogurova M., Radulesku G., Viktorovich T., Chavpetsova E., Shats L., Uleiskaya G., Martynkevich I., Ogorodnikova Y., Zueva E. RESULTS OF ACUTE LYMPHOBLASTIC LEUKEMIA TREATMENT WITH INTENSIVE CHEMOTHERAPY IN CHILDREN IN ST.-PETERSBURG: RETROSPECTIVE EVALUATION OF TWO VERSIONS OF COALL-92 PROTOCOL. Current Pediatrics. 2011;10(3):33-42.
Email this article 
